Iressa Expanded Access Program (EAP)
NCT00034879
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Carcinoma
Non-small-cell Lung
Metastases
Neoplasm
Interventions
DRUG:
ZD1839 (Gefitinib)
Sponsor
AstraZeneca